AbCellera Biologics (ABCL) Current Taxes (2020 - 2022)
Historic Current Taxes for AbCellera Biologics (ABCL) over the last 3 years, with Q3 2022 value amounting to $23.0 million.
- AbCellera Biologics' Current Taxes rose 24928.68% to $23.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.0 million, marking a year-over-year increase of 24928.68%. This contributed to the annual value of $35.7 million for FY2021, which is 129.73% down from last year.
- According to the latest figures from Q3 2022, AbCellera Biologics' Current Taxes is $23.0 million, which was up 24928.68% from $107.3 million recorded in Q2 2022.
- AbCellera Biologics' Current Taxes' 5-year high stood at $107.3 million during Q2 2022, with a 5-year trough of $5.8 million in Q2 2021.
- Moreover, its 3-year median value for Current Taxes was $32.9 million (2021), whereas its average is $43.8 million.
- As far as peak fluctuations go, AbCellera Biologics' Current Taxes crashed by 129.73% in 2021, and later skyrocketed by 174338.72% in 2022.
- AbCellera Biologics' Current Taxes (Quarter) stood at $36.2 million in 2020, then fell by 1.3% to $35.7 million in 2021, then plummeted by 35.49% to $23.0 million in 2022.
- Its Current Taxes was $23.0 million in Q3 2022, compared to $107.3 million in Q2 2022 and $105.6 million in Q1 2022.